Corrigendum to "Substrate based peptide aldehyde inhibits bacterial type I signal peptidase" [Bioorg. Med. Chem. Lett. 19 (2009) 2880] (DOI:10.1016/j.bmcl.2009.03.064);Substrate based peptide aldehyde inhibits bacterial type I signal peptidase

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 10, 2009, Pages 2880-2883

  Buzder Lantos, Peter ^a   Bockstael, Katrijn ^a   Anné, Jozef ^a   Herdewijn, Piet ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antibiotics; Peptides; Signal peptidase; Structure activity relationship

Indexed keywords

ALDEHYDE DERIVATIVE; AMINO ACID; ENZYME INHIBITOR; LIPOPEPTIDE; PEPTIDE DERIVATIVE; SIGNAL PEPTIDASE I; SIGNAL PEPTIDASE I INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME INHIBITION; ESCHERICHIA COLI; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); SACCHAROMYCES;

EID: 65349139603     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.03.169     Document Type: Erratum

References (26)

1. Date T. J. Bacteriol. 154 (1983) 76
2. Cregg K.M., Wilding I., and Black M.T. J. Bacteoriol. 178 (1996) 5712
3. Koshland D., Sauer R.T., and Botstein D. Cell 30 (1982) 903
4. Dalbey R.E., and Wickner W. J. Biol. Chem. 260 (1985) 15925
5. Sung M., and Dalbey R.E. J. Biol. Chem. 267 (1992) 13154
6. Dalbey R.E., Lively M.O., Bron S., and Van Dijl J.M. Protein Sci. 6 (1997) 1129
7. Von Heijne G. J. Membr. Biol. 115 (1990) 195
8. Allsop A.E., Brooks G., Bruton G., Coulton S., Edwards P.D., Hatton I.K., Kaura A.C., McLean S.D., Pearson N.D., Smale T.C., and Southgate R. Bioorg. Med. Chem. Lett. 5 (1995) 443
9. Perry C.R., Ashby M.J., and Elsmere S.A. Biochem. Soc. Trans. 23 (1995) 548
10. Schimana J., Gebhardt K., Holtzel A., Schmid D.G., Sussmuth R., Muller J., Pukall R., and Fiedler H.P. J. Antibiot. 55 (2002) 565
11. Kulanthaivel P., Kreuzman A.J., Strege M.A., Belvo M.D., Smitka T.A., Clemens M., Swartling J.R., Minton K.L., Zheng F., Angleton E.L., Mullen D., Jungheim L.N., Klimkowski V.J., Nicas T.I., Thompson R.C., and Peng S.B. J. Biol. Chem. 279 (2004) 36250
12. Von Heijne G. Eur J. Biochem. 133 (1983) 17
13. Von Heijne G. J. Mol. Biol. 184 (1985) 99
14. Paetzel M., Dalbey R.E., and Strynadka N.C.J. Nature 396 (1998) 186
15. Black M.T., Munn J.G., and Allsop A.E. Biochem. J. 282 (1992) 539
16. Kim Y.T., Muramatsu T., and Takahashi K. J. Biochem. 117 (1992) 535
17. Black M.T., and Bruton G. Curr. Pharm. Des. 4 (1998) 133
18. Allsop A., Brooks G., Edwards P.D., Kaura A.C., and Southgate R. J. Antibiot. 49 (1996) 921
19. Barkocy-Gallagher G.A., and Bassford P.J. J. Biol. Chem. 267 (1992) 1231
20. Nilsson I., and Von Heine G. FEBS Lett. 299 (1992) 243
21. Bruton G., Huxley A., O'Hanlon P., Orlek B., Eggleston D., Humphries D., Readshaw S., West A., Ashman S., Brown M., Moore K., Pope A., O'Dwyer K., and Wang L. Eur. J. Med. Chem. 38 (2003) 351
22. Solid phase peptide synthesis was performed on Wang resin using classical coupling reagents for peptide bond formation and Fmoc protected amino acids. Synthesis was terminated by N-terminal decanoylation followed by side chain deprotection and cleavage from the solid support using a mixture of TFA/water/thioanisole (95:5:5) following the general deprotection-cleavage procedure. Crude peptides were purified by semi-preparative RP-HPLC. Compounds were characterized by accurate mass spectrometry.
23. Zhong W., and Benkovic S.J. Anal. Biochem. 255 (1998) 66
24. National Committee for Clinical Laboratory Standards. Approved standard: M7-A6. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th Edition (2003), National Committee for Clinical Laboratory Standards, Wayne, PA
25. Compound 11 was purchased from Cambridge Peptides. The synthesis was carried out on a Weinreb AM resin followed by the reduction of the Weinreb amide to the protected peptide aldehyde by lithium aluminum hydride. Finally protecting groups were removed by treatment with trifluoro acetic acid. The crude peptide aldehyde was purified by HPLC.
26. Gazal S., Masterson L.R., and Barany G. J. Pept. Res. 66 (2005) 324